» Articles » PMID: 7677180

Endotoxin Stimulates Expression of the Murine Urokinase Receptor Gene in Vivo

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1995 Sep 1
PMID 7677180
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The regulation of urokinase receptor (u-PAR) gene expression during endotoxemia was studied in vivo with a murine model system. Northern blot analysis demonstrated relatively high levels of u-PAR mRNA in mouse placenta, with intermediate levels in lung and spleen and very low levels in heart and kidney. No u-PAR mRNA could be detected in liver, gut, thymus, brain, or skeletal muscle. Intraperitoneal injection of endotoxin (lipopolysaccharide) increased the steady-state levels of u-PAR mRNA in most tissues examined. The greatest induction (sevenfold) was observed in the lung at 1 hour after injection. The cellular localization of u-PAR mRNA was assessed by in situ hybridization. In control mice, u-PAR mRNA was detected primarily in alveolar macrophages of the lung and lymphocytes of the spleen and thymus, although a specific signal was also present in other cell types. In general, endothelial cells lacked detectable u-PAR mRNA. The induction of u-PAR mRNA by lipopolysaccharide was apparent within 30 minutes and was localized to tissue macrophages, lymphocytes, and endothelial cells lining arteries and veins. At later times (1 to 3 hours), specialized epithelial cells present in gastrointestinal tract, bile ducts, and uterus were also positive for u-PAR mRNA. Induction of u-PAR in vivo by lipopolysaccharide may facilitate the extravasation and migration of leukocytes during inflammation.

Citing Articles

suPAR, a Circulating Kidney Disease Factor.

Wei C, Spear R, Hahm E, Reiser J Front Med (Lausanne). 2021; 8:745838.

PMID: 34692736 PMC: 8526732. DOI: 10.3389/fmed.2021.745838.


Physiology and pathophysiology of the plasminogen system in the kidney.

Svenningsen P, Hinrichs G, Zachar R, Ydegaard R, Jensen B Pflugers Arch. 2017; 469(11):1415-1423.

PMID: 28656379 DOI: 10.1007/s00424-017-2014-y.


Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.

Wang H, Hicks J, Khanbolooki P, Kim S, Yan C, Wang Y Am J Pathol. 2003; 163(2):453-64.

PMID: 12875967 PMC: 1868205. DOI: 10.1016/S0002-9440(10)63675-9.


Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia.

Juffermans N, Dekkers P, Verbon A, Speelman P, van Deventer S, van der Poll T Infect Immun. 2001; 69(8):5182-5.

PMID: 11447203 PMC: 98617. DOI: 10.1128/IAI.69.8.5182-5185.2001.


Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia.

Dekkers P, Ten Hove T, Te Velde A, van Deventer S, van der Poll T Infect Immun. 2000; 68(4):2156-60.

PMID: 10722614 PMC: 97398. DOI: 10.1128/IAI.68.4.2156-2160.2000.


References
1.
Suffredini A, HARPEL P, Parrillo J . Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med. 1989; 320(18):1165-72. DOI: 10.1056/NEJM198905043201802. View

2.
Kirchheimer J, Nong Y, Remold H . IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes. J Immunol. 1988; 141(12):4229-34. View

3.
Behrendt N, Ronne E, Ploug M, Petri T, Lober D, Nielsen L . The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem. 1990; 265(11):6453-60. View

4.
Raetz C . Biochemistry of endotoxins. Annu Rev Biochem. 1990; 59:129-70. DOI: 10.1146/annurev.bi.59.070190.001021. View

5.
Estreicher A, Muhlhauser J, Carpentier J, Orci L, Vassalli J . The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol. 1990; 111(2):783-92. PMC: 2116194. DOI: 10.1083/jcb.111.2.783. View